SCHEMBL28055261

SCHEMBL28055261

CCN1CCN(c2ccc(N)nc2)C[C@H]1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.42
DRD3 P35462 2/20 0.42
DRD4 P21917 1/20 0.42
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
CHEK1 O14757 1/20 0.39
CHRNB2 P17787 1/20 0.38
CHRNA4 P43681 1/20 0.38
MTOR P42345 2/20 0.37
TRPC6 Q9Y210 5/20 0.37
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
RAD52 P43351 1/20 0.36
GFER P55789 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ADORA2A P29274 3/20 0.35
ADORA1 P30542 1/20 0.35
KCNH2 Q12809 1/20 0.35
GCK P35557 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28055263 1.00 DRD2 (0.42) DRD2DRD3DRD4ESR1ESR2
SCHEMBL611882 0.77 GAA (0.62) TRPC6KDM4EGAAMAPTRAD52
SCHEMBL13349179 0.77 ESR1 (0.46) ESR1ESR2CHEK1KDM4EGAA
SCHEMBL30664067 0.77 GAA (0.62) TRPC6KDM4EGAAMAPTRAD52
SCHEMBL28055262 0.77 DRD2 (0.40) DRD2DRD3DRD4MTORKCNH2
SCHEMBL28055260 0.77 DRD2 (0.40) DRD2DRD3DRD4MTORKCNH2
SCHEMBL15857990 0.76 ESR1 (0.45) DRD2DRD4ESR1ESR2KDM4E
SCHEMBL18948533 0.76 KMT2A (0.49) DRD2DRD4ESR1ESR2KDM4E
SCHEMBL28282066 0.75 CHRNB2 (0.50) CHRNB2CHRNA4ADORA2AADORA1KCNH2
SCHEMBL28282064 0.75 CHRNB2 (0.50) CHRNB2CHRNA4ADORA2AADORA1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105294655-A CDK small-molecule inhibitor compounds and application therefore GUANGDONG HEC PHARMACEUTICAL 2016-02-03 CN disclosed